Chris Ahuja

CEO and CMO

Chris Ahuja picture

Chris Ahuja

Inteligex

CEO and CMO

Inteligex is a biotechnology company developing therapies to reduce the tremendous disability and costs incurred by those living with brain and spinal cord injuries (SCI). Currently, there are no effective regenerative treatments for the central nervous system (CNS). Inteligex has developed bioengineered neural stem cell-based products that are specifically designed to integrate into the CNS injury microenvironment and have demonstrated significantly enhanced functional recovery in high-fidelity preclinical models of SCI. These patent-protected technologies are now being prepared for GMP manufacturing and clinical trial.